Total Payments
$8,627
2024 Payments
$560.74
Companies
65
Transactions
350
Medicare Patients
10,762
Medicare Billing
$4.0M
Payment Breakdown by Category
Food & Beverage$7,650 (88.7%)
Education$776.65 (9.0%)
Other$200.00 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,650 | 329 | 88.7% |
| Education | $776.65 | 20 | 9.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $812.91 | 25 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $653.29 | 34 | $0 (2023) |
| Janssen Biotech, Inc. | $595.16 | 39 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $481.42 | 12 | $0 (2023) |
| PFIZER INC. | $445.27 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $344.57 | 17 | $0 (2024) |
| Seagen Inc. | $305.33 | 14 | $0 (2023) |
| Kite Pharma, Inc. | $281.91 | 12 | $0 (2023) |
| Lilly USA, LLC | $280.02 | 9 | $0 (2023) |
| Merck Sharp & Dohme LLC | $272.77 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $560.74 | 23 | Novartis Pharmaceuticals Corporation ($87.40) |
| 2023 | $1,677 | 72 | Janssen Biotech, Inc. ($144.47) |
| 2022 | $951.22 | 38 | Amgen Inc. ($201.43) |
| 2021 | $1,442 | 62 | Amgen Inc. ($276.17) |
| 2020 | $978.62 | 41 | Amgen Inc. ($131.69) |
| 2019 | $1,140 | 43 | Pharmacyclics LLC, An AbbVie Company ($157.58) |
| 2018 | $1,156 | 40 | Rigel Pharmaceuticals, Inc. ($213.00) |
| 2017 | $722.47 | 31 | Lilly USA, LLC ($122.94) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 07/24/2024 | Genentech USA, Inc. | Lunsumio (Biological) | Food and Beverage | In-kind items and services | $30.31 | General |
| Category: BioOncology | ||||||
| 03/14/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.13 | General |
| Category: Hematology/Oncology | ||||||
| 03/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: ONCOLOGY | ||||||
| 03/12/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug), TALVEY, TECVAYLI | Food and Beverage | In-kind items and services | $31.82 | General |
| Category: Oncology | ||||||
| 03/12/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Oncology | ||||||
| 03/08/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: ONCOLOGY | ||||||
| 03/07/2024 | PFIZER INC. | INLYTA (Drug), XTANDI, TALZENNA | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: ONCOLOGY | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Oncology | ||||||
| 03/04/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Oncology | ||||||
| 02/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: ONCOLOGY | ||||||
| 02/21/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: ONCOLOGY | ||||||
| 02/14/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: ONCOLOGY | ||||||
| 02/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $35.35 | General |
| Category: Oncology | ||||||
| 02/01/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Immunology | ||||||
| 01/31/2024 | PFIZER INC. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $31.99 | General |
| Category: Oncology | ||||||
| 01/29/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Oncology | ||||||
| 01/26/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: ONCOLOGY | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug), PLUVICTO | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 01/23/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: DESMOID TUMORS | ||||||
| 01/11/2024 | GENZYME CORPORATION | CABLIVI (Biological), ENJAYMO | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Hematology | ||||||
| 01/08/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: IMMUNOLOGY | ||||||
| 01/04/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Oncology | ||||||
| 12/19/2023 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $37.98 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2023 | PFIZER INC. | OXBRYTA (Drug) | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: HEMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,493 | 67,951 | $4.8M | $1.3M |
| 2022 | 39 | 2,652 | 68,654 | $3.5M | $842,093 |
| 2021 | 45 | 2,875 | 50,385 | $2.5M | $850,486 |
| 2020 | 49 | 2,742 | 58,910 | $3.0M | $995,925 |
Total Patients
10,762
Total Services
245,900
Medicare Billing
$4.0M
Procedure Codes
171
All Medicare Procedures & Services
171 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 13 | 12,500 | $1.4M | $494,386 | 34.4% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 11 | 5,970 | $1.1M | $213,572 | 19.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 25 | 6,720 | $366,240 | $124,904 | 34.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 550 | 1,221 | $256,410 | $96,121 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 709 | $216,245 | $80,646 | 37.3% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 42 | 11,480 | $519,470 | $68,094 | 13.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 55 | 302 | $155,228 | $42,152 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 106 | 217 | $88,102 | $34,785 | 39.5% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 24 | 280 | $57,960 | $21,629 | 37.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 41 | 168 | $40,992 | $11,136 | 27.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 141 | $31,302 | $9,977 | 31.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 220 | 1,002 | $15,030 | $8,417 | 56.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 44 | 274 | $30,962 | $8,230 | 26.6% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 17 | 20,400 | $102,000 | $8,121 | 8.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 208 | 972 | $42,768 | $7,385 | 17.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 83 | 533 | $39,975 | $7,274 | 18.2% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 24 | 69 | $19,251 | $6,801 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $20,284 | $6,753 | 33.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 48 | 63 | $21,861 | $6,729 | 30.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 124 | 580 | $33,640 | $5,995 | 17.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 41 | 298 | $23,542 | $4,779 | 20.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 26 | $15,210 | $3,934 | 25.9% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 13 | 53 | $13,303 | $3,660 | 27.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 27 | 103 | $11,433 | $3,026 | 26.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 70 | 197 | $12,805 | $2,632 | 20.6% |
About Dr. Robert Robles, M.D
Dr. Robert Robles, M.D is a Hematology & Oncology healthcare provider based in Pleasant Hill, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518963958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Robles, M.D has received a total of $8,627 in payments from pharmaceutical and medical device companies, with $560.74 received in 2024. These payments were reported across 350 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($7,650).
As a Medicare-enrolled provider, Robles has provided services to 10,762 Medicare beneficiaries, totaling 245,900 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 171 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Pleasant Hill, CA
- Active Since 06/21/2005
- Last Updated 08/02/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1518963958
Products in Payments
- OPDIVO (Biological) $483.83
- Imbruvica (Drug) $361.01
- IMBRUVICA (Drug) $275.62
- Tavalisse (Drug) $232.65
- KEYTRUDA (Biological) $229.22
- ERLEADA (Drug) $207.40
- PADCEV (Biological) $206.83
- LUMAKRAS (Drug) $200.53
- CYRAMZA (Drug) $186.18
- ANDEXXA (Biological) $182.25
- INLYTA (Drug) $121.41
- Rubraca (Drug) $118.48
- Enhertu (Drug) $116.72
- JEVTANA (Drug) $104.66
- TUKYSA (Drug) $103.73
- Braftovi (Drug) $102.02
- ZALTRAP (Drug) $99.99
- SARCLISA (Biological) $98.43
- CALQUENCE (Drug) $90.78
- Blincyto (Biological) $82.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Pleasant Hill
Dr. Gigi Chen, M.d, M.D
Hematology & Oncology — Payments: $132,511
Hematology & Oncology $132,511
Dr. Shoba Kankipati, M.d, M.D
Hematology & Oncology — Payments: $71,127
Hematology & Oncology $71,127
Dr. Leann Blankenship, M.d, M.D
Hematology & Oncology — Payments: $18,600
Hematology & Oncology $18,600
Donna Saba, Fnp, FNP
Hematology & Oncology — Payments: $16,904
Hematology & Oncology $16,904
Yelena Krupitskaya, M.d, M.D
Hematology & Oncology — Payments: $9,191
Hematology & Oncology $9,191
Tiffany Svahn, M.d, M.D
Hematology & Oncology — Payments: $5,476
Hematology & Oncology $5,476